BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 24224572)

  • 1. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
    Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
    Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential scanning calorimetry predicts the critical quality attributes of amorphous glibenclamide.
    Mah PT; Laaksonen T; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Sci; 2015 Dec; 80():74-81. PubMed ID: 26296864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Eur J Pharm Biopharm; 2012 Feb; 80(2):459-64. PubMed ID: 22019529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
    Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
    Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
    Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
    Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.
    Branham ML; Moyo T; Govender T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):194-202. PubMed ID: 21906676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways.
    Edueng K; Mahlin D; Larsson P; Bergström CAS
    J Control Release; 2017 Jun; 256():193-202. PubMed ID: 28412224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the amorphous glibenclamide drug: analysis of the molecular dynamics of quenched and cryomilled material.
    Wojnarowska Z; Grzybowska K; Adrjanowicz K; Kaminski K; Paluch M; Hawelek L; Wrzalik R; Dulski M; Sawicki W; Mazgalski J; Tukalska A; Bieg T
    Mol Pharm; 2010 Oct; 7(5):1692-707. PubMed ID: 20669906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
    Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
    Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions.
    Bøtker JP; Karmwar P; Strachan CJ; Cornett C; Tian F; Zujovic Z; Rantanen J; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):112-9. PubMed ID: 21182911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
    Mohammad MA; Grimsey IM; Forbes RT
    J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Nanometric Solid Dispersions of Glibenclamide in Neusilin(®) UFL2.
    Censi R; Gigliobianco MR; Dubbini A; Malaj L; Di Martino P
    AAPS PharmSciTech; 2016 Oct; 17(5):1204-12. PubMed ID: 26645108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.
    Salazar J; Ghanem A; Müller RH; Möschwitzer JP
    Eur J Pharm Biopharm; 2012 May; 81(1):82-90. PubMed ID: 22233547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
    Aucamp M; Milne M; Liebenberg W
    AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
    Feng T; Bates S; Carvajal MT
    Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.